Similar Articles
191 Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
192 Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
193 Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing
194 Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
195 Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis
196 Oncometabolites in pancreatic cancer: Strategies and its implications
197 Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
198 Hepatocellular carcinoma national burden across different geographical regions in the United States between 2001 and 2020
199 Imaging-based prediction of hepatocellular carcinoma recurrence after microwave ablation as bridge therapy: A glimpse into the future
200 Gene targets with therapeutic potential in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA